Professor, Neurology, University of Virginia School of Medicine

Neurology

Burns is an expert in the field of Neurology. He researched medicine at University of Kansas School of Medicine. He over the years received 12 awards: "MGFA National Doctor of the Year", "Chair, Neuromuscular Section of the AAN", "Chair, Medical/Scientific Advisory Board", "Executive Committee, Elected", "Academy of Distinguished Educators", "Early Career Achievement Award", "Harrison Distinguished Professor", "Editor in Chief, Neurology Podcast", "Creator and Editor of AANEM Neuromuscular Podcast", "Best Doctors, 2005-present", "Master Educator Award" and "CMS Meaningful Use Stage 1 Certification". Burns has written publications. He has 75 publications published with PubMed. The lastest publication is: 'Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.' Burns accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.
• The Best of Both Worlds: Using patient-reported plus physician-scored measures during the evaluation of myasthenia gravis.
• Clinical profile of patients with myasthenia gravis followed at the University Hospital, Federal University of Minas Gerais.
• Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis.
• Two steps forward one step back; Mycophenolate mofetil use for myasthenia gravis in the United States.
• Reevaluating clinical measurement tools in therapeutic trials: Time to make a Rasch decision?
• Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis.
• The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.
• Neurologic indications for therapeutic plasma exchange: 2013 update.
• Vasculitic neuropathies.
• Electrical impedance myography correlates with standard measures of ALS severity.
• Brazilian cross-cultural translation and adaptation of the "Questionnaire of Life Quality Specific for Myasthenia Gravis - 15 items".
• Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?
• A Randomized, double-blind, placebo-controlled Phase II study of eculizumab in patients with refractory generalized myasthenia gravis.
• Phase II trial of methotrexate in myasthenia gravis.
• Reply: To PMID 22581550.
• The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice.
• "Measure twice, cut once": Improving diagnostic accuracy of skin biopsy.
• The Neurology(R) Podcast: 2007-2012: Can you hear me now?
• Electrical impedance myography as a biomarker to assess ALS progression.
• More than meets the eye: The benefits of listening closely to what our patients with myasthenia gravis are telling us.
• Quality of life and measures of quality of life in patients with neuromuscular disorders.
• Psychometric evaluation of the myasthenia gravis composite using Rasch analysis.
• Recommendations for myasthenia gravis clinical trials.
• Neurologic indications for therapeutic plasma exchange: 2011 update.
• The Oculobulbar Facial Respiratory score is a tool to assess bulbar function in myasthenia gravis patients.
• The evaluation of polyneuropathies.
• The authorship lottery: an impediment to research collaboration?
• History of outcome measures for myasthenia gravis.
• Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.
• Clinical applications of therapeutic apheresis.
• Case of the month: leukemic nerve infiltration.
• Pearls and Oy-sters: evaluation of peripheral neuropathies.
• Neuroleukemiosis: case report of leukemic nerve infiltration in acute lymphoblastic leukemia.
• The more the merrier?
• Neuromuscular disorders. Preface.
• The evaluation of chronic axonal polyneuropathies.
• Guillain-Barré syndrome.
• The forecast for podcasts: sunny skies but not necessarily with clear visibility.
• Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm.
• Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia.
• An easy approach to evaluating peripheral neuropathy.
• Myotonic dystrophy.
• Management of common neurologic conditions in sports.
• Neuromuscular complications of cancer diagnosis and treatment.
• Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies.
• Chronic inflammatory demyelinating polyradiculoneuropathy.
• Multifocal slowing of nerve conduction in metachromatic leukodystrophy.
• Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome.
• Current therapeutic strategies for patients with polyneuropathies secondary to inherited metabolic disorders.
• Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome.
• Clinical versus quantitative vibration assessment: improving clinical performance.
• Peroneal neuropathy following successful bariatric surgery. Case report and review of the literature.
• Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia.
• Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
• Gasoline sniffing multifocal neuropathy.
• Multipoint incremental motor unit number estimation as an outcome measure in ALS.
• Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy.
• Neurologic indications for therapeutic plasma exchange: an update.
• The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases.
• Adynamic ileus in severe Guillain-Barré syndrome.
• Neuroendocrine lung tumors and disorders of the neuromuscular junction.
• Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
• Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter.
• A step forward for stiff-person syndrome.
• An update on the classification and treatment of vasculitic neuropathy.
• Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.
• R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS.
• Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite.
• Construct and concurrent validation of the MG-QOL15 in the practice setting.
• Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy.
• The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
• The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis.
• MG-ADL: still a relevant outcome measure.

Schools

---

• Ks Hegde Medical Academy Medical Sciences Complex

• Mayo Clinic

• University Of Virginia

Procedures Preformed

---

• EEG (Electroencephalogram)
• EMG (Electromyography)

Doctors Specialties

---

• Clinical Neurophysiology
• Neurology

Accepted Insurances

---

Awards

---

• MGFA National Doctor of the Year
• Chair, Neuromuscular Section of the AAN
• Chair, Medical/Scientific Advisory Board
• Executive Committee, Elected
• Academy of Distinguished Educators
• Early Career Achievement Award
• Harrison Distinguished Professor
• Editor in Chief, Neurology Podcast
• Creator and Editor of AANEM Neuromuscular Podcast
• Best Doctors, 2005-present
• Master Educator Award
• CMS Meaningful Use Stage 1 Certification

Education

---

• Mayo School of Graduate Medical Education
• University of Virginia
• University of Kansas School of Medicine

Hospital

---

• University of Virginia Medical Center

Drug Facts

---

NPI NUMBER		1679642292
NPPES Provider LastName		BURNS
NPPES Provider FirstName		TED
NPPES Provider ZIPCode		229080001
NPPES Provider State		VA
Specialty Description		Neurology
Total Claim Count		104.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1679642292
Last Name Of The Provider	BURNS
First Name Of The Provider	TED
View All

Similar Doctors

---

	Dr. Daniel O. Claassen, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew J. Barrett, MD
	Dr. Howard P. Goodkin, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew H. Wong, MD
	Dr. Russell C. Bailey, MD
	Dr. Jennifer E. Langer, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark S. Quigg, MD This Doctor is OpenDoctor Recommended.
	Dr. Nina J. Solenski, MD This Doctor is OpenDoctor Recommended.
	Dr. William R. Hobbs, MD
	Dr. John R. Scagnelli, MD This Doctor is OpenDoctor Recommended.
	Dr. Daryl R. Gress, MD This Doctor is OpenDoctor Recommended.
	Dr. Lawrence H. Phillips Jr., MD
	Dr. Rafal M. Smigrodzki, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher J. Scherer, MD This Doctor is OpenDoctor Recommended.
	Dr. David H. Taplinger, MD
	Dr. Michael E. Brogan, MD This Doctor is OpenDoctor Recommended.
	Dr. Jasmin T. Jo, MD
	Dr. Heba H. Afeefy, MD
	Dr. Bryan J. Cupka, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher L. Groth, MD
	Dr. David A. Lapides, MD
	Dr. Philip H. Tseng, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog